I knew that it takes years, even decades, for modern vaccines to reach the under-resourced regions of the world – yet most of the deaths from infectious disease occur there. I also knew that state-of-the-art vaccines are often far too expensive for mass campaigns in developing countries.

Mark Kendall, 2012 Rolex Laureate, Science & HealthRead more

A bridge to the future

Rolex and EPFL

Rolex has had a long, mutually rewarding relationship with the EPFL, the world-leading Swiss Federal Institute of Technology in Lausanne.

Share this page